Last updated on January 2009

Donepezil Double Blind Trial for ECT Memory Disfunction

Brief description of study

This is a double blind randomized investigation of donepezil for patients suffering from schizophrenia, undergoing ECT. Patients will be randomized to receive either donezepil or plasebo, in order to gauge whether donezepil has a protective effect on memory disfunction, while patients are treated with ECT. Several parameters will be invistigated at baseline: general psychopathological measures, memory function scales, side effects scales. The same measurements will be taken throughout the trial and one month after ending the ECT.

Clinical Study Identifier: NCT00465283

Contact Investigators or Research Sites near you

Start Over

Tali Nachshoni, MD

Beer Yaakov MHC
Beer Yaacov, Israel
  Connect »